Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects.
about
EEG machine learning for accurate detection of cholinergic intervention and Alzheimer's disease.The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT3 receptors.Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine.Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.Pharmacokinetics and pharmacodynamics of oral mecamylamine - development of a nicotinic acetylcholine receptor antagonist cognitive challenge test using modelling and simulation.Time related effects on functional brain connectivity after serotonergic and cholinergic neuromodulation.Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjectsCase report: Hyperthermia and diminished consciousness in an elderly woman following an accidental overdose of scopolamine.An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine.
P2860
Q33915806-72B7E380-44E2-403B-A448-34D756DB0668Q37037197-0D8325F8-DC91-430E-BF42-164488611168Q37297958-71FC9EBF-8740-444B-A1A8-EF0E0754F717Q38204833-25DD8B39-6E7A-4648-8A04-309B077C46B2Q38786004-091594D5-BECC-4150-8354-AA7479E72C76Q40810950-B3B5F5AD-5008-4E09-B497-0E7E06797F09Q41634921-B4C762A6-1763-41DD-A5F1-578914732603Q48176079-60BCFB2D-6844-454A-9827-AFDAB6B9FCB1Q48219255-CC7BFC10-4610-46BF-BA81-D0165EB11469
P2860
Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pharmacokinetic-pharmacodynami ...... opolamine in healthy subjects.
@en
Pharmacokinetic-pharmacodynami ...... opolamine in healthy subjects.
@nl
type
label
Pharmacokinetic-pharmacodynami ...... opolamine in healthy subjects.
@en
Pharmacokinetic-pharmacodynami ...... opolamine in healthy subjects.
@nl
prefLabel
Pharmacokinetic-pharmacodynami ...... opolamine in healthy subjects.
@en
Pharmacokinetic-pharmacodynami ...... opolamine in healthy subjects.
@nl
P2093
P2860
P1476
Pharmacokinetic-pharmacodynami ...... copolamine in healthy subjects
@en
P2093
Joop M A van Gerven
Maarten Timmers
Marieke Liem-Moolenaar
Peter de Boer
Stephan Schmidt
P2860
P304
P356
10.1111/J.1365-2125.2011.03936.X
P407
P577
2011-06-01T00:00:00Z